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Abstract.  The subcellular distribution of phospholam- 
ban in adult canine ventricular myocardial cells was 
determined by the indirect immunogold-labeling tech- 
nique.  The results presented suggest that phospholam- 
ban, like the Ca2+-ATPase, is uniformly distributed in 
the network sarcoplasmic reticulum but absent from 
the junctional portion of the junctional sarcoplasmic 
reticulum.  Unlike the Ca2÷-ATPase, but like cardiac 
calsequestrin,  phospholamban also appears to be pres- 
ent in the corbular sarcoplasmic reticulum.  Compari- 
son of the relative distribution of phospholamban im- 
munolabeling in the sarcoplasmic reticulum with that 
of the sarcolemma showed that the density of phos- 
pholamban in the network sarcoplasmic reticulum was 
•35-fold  higher than that of the cytoplasmic side of 
the sarcolemma,  which in turn was found to be three- 
to fourfold higher than the density of the background 
labeling.  However, a majority of the specific phos- 
pholamban labeling within 30 nm of the cytoplasmic 
side of the sarcolemma was clustered and present over 
the sarcoplasmic reticulum in the subsarcolemmal re- 
gion of the myocardial cells, suggesting that phos- 
pholamban is confined to the junctional regions be- 
tween the sarcolemma and the sarcoplasmic reticulum, 
but absent from the nonjunctional portion of the sar- 
colemma.  Although the resolution of the immunogold- 
labeling technique used (60 nm) does not permit one 
to determine whether the specific labeling within 30 
nm of the cytoplasmic side of the sarcolemma is as- 
sociated with the sarcolemma and/or the junctional 
sarcoplasmic reticulum,  it is likely that the low 
amount of labeling in this region represents phos- 
pholamban associated with sarcoplasmic reticulum. 
These results suggest that phospholamban is absent 
from the sarcolemma and confined to the sarcoplasmic 
reticulum in cardiac muscle. 
T 
HE key regulator of the contraction relaxation cycle of 
cardiac muscle cells is Ca  2÷. It is generally accepted 
that the sarcoplasmic reticulum  together with the sar- 
colemma regulates the Ca  2+ fluxes in the myofibril (2, 9, 19, 
32, 35). The ability of beta-adrenergic  agonists to enhance 
the contractility  and rate of relaxation in cardiac muscle cells 
is believed to be mediated by transient  changes  in the Ca  2÷ 
transport properties of the sarcoplasmic reticulum and/or the 
sarcolemma (9, 30-32). 
Phospholamban is the main membrane protein of cardiac 
sarcoplasmic  reticulum  to  become phosphorylated  in  re- 
sponse to perfusion of hearts with beta-adrenergic  agonists 
(20).  Since beta-adrenergic  agonists cause an increase in in- 
traceUular  cAMP concentration  in myocardium, which in 
turn is associated with cAMP-activated  phosphorylation of 
phospholamban  and  stimulation  of Ca2+-transport  by sar- 
coplasmic reticulum (17, 20, 30, 31), it has been proposed that 
the increase in the rate of relaxation  of cardiac muscle pro- 
duced by beta-adrenergic  agonists is at least in part mediated 
by the cAMP-activated  phosphorylation of phospholamban 
(20, 30, 31). Assuming that the sole function of phospholam- 
ban is to enhance Ca  2+ uptake  by the Ca2+-ATPase of sar- 
coplasmic reticulum, one would predict that phospholamban 
and the Ca2+-ATPase should colocalize in this  membrane 
system. However, on the basis of in vitro (26, 27) and in situ 
(7, 8) studies  on the phosphorylation of sarcolemmal  pro- 
teins, it has been reported that a phospholamban-like  protein 
called calciductin  is  also present  in  isolated  cardiac  sar- 
colemmal vesicles.  Furthermore, it has been suggested that 
beta-adrenergic-stimulated  phosphorylation  of the  sarco- 
lemmal-associated  phospholamban enhances  the Ca  2÷ flux 
into the myocardial cells via the voltage-gated Ca  >  channel 
during  the depolarization  of the sarcolemma (26, 27). This 
possibility is, however, disputed by biochemical studies sug- 
gesting  that  the  phospholamban-like  protein  detected  in 
cardiac  sarcolemmal  vesicles  is present as a  contaminant 
(9, 22). 
Ultrastructural  studies have previously suggested that the 
sarcoplasmic reticulum  of mammalian  cardiac myocytes is 
composed of at least three structurally  distinct but continu- 
ous regions  (1, 4, 28, 29). They are called the network, the 
junctional,  and  the corbular sarcoplasmic  reticulum.  The 
network sarcoplasmic reticulum consists of an anastomosing 
network of electron lucent sarcotubules and surrounds the 
myofibrils. The junctional and corbular sarcoplasmic reticu- 
lum both contain electron dense material in their lumens and 
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plasmic surface. The junctional sarcoplasmic reticulum is 
bridged to the sarcolemma or its derivative, the transverse 
tubules, via electron dense structures called "feet" (6).  The 
corbular sarcoplasmic reticulum, composed of corbular and 
cisternal expansions on the network sarcoplasmic reticulum, 
is mainly localized at the Z-line region in the interior regions 
of the myocardial cells. It is not closely apposed to either the 
sarcolemma or the transverse tubules. 
It has previously been shown by immunoelectron micro- 
scopical  labeling that the Ca2+-ATPase is  confined to the 
sarcoplasmic reticulum in cardiac muscle where it is uni- 
formly  distributed in the network sarcoplasmic reticulum but 
apparently absent from the junctional portion of both the in- 
terior and the peripheral junctional sarcoplasmic reticulum 
(15).  Freeze fracture studies  suggest that it is also absent 
from the corbular sarcoplasmic reticulum (1). To ascertain 
whether phospholamban like the Ca2+-ATPase of the sar- 
coplasmic  reticulum (15) is  confined to the network sar- 
coplasmic reticulum or whether phospholamban is also a 
component of the cardiac sarcolemma, as proposed by sev- 
eral investigators (7, 8, 26, 27), we have determined the sub- 
cellular distribution of phospholamban in adult canine ven- 
tricular muscle cells by the indirect immunofluorescence  and 
immunogold  labeling  techniques.  The  results  presented 
show that phospholamban is densely distributed throughout 
the sarcoplasmic reticulum but is apparently absent from the 
sarcolemma, including the transverse tubules and the inter- 
calated discs joining adjacent ventricular cells. Within the 
sarcoplasmic reticulum, phospholamban appears to be uni- 
formly distributed in the network and the corbular sarcoplas- 
mic reticulum but apparently absent from the junctional por- 
tion of the junctional sarcoplasmic reticulum. 
Figure  1.  Immunoblot  show- 
ing  specificity  of  affinity-pu- 
rified  antibodies  to  canine 
ventricular  phospholamban. 
Canine ventricular  sarcoplas- 
mic  reticulum  proteins  (SR) 
and  purified  phospholamban 
(PLB) were separated by SDS 
PAGE  and  subjected  to  elec- 
trophoresis  onto  nitrocellu- 
lose  (24).  The  nitrocellulose 
sheet  containing  the  trans- 
ferred  proteins  was  first  in- 
cubated  with  afffinity-purified 
antibodies  to  canine  cardiac 
phospholamban and then with 
horseradish  peroxidase  con- 
jugated to affinity-purified goat 
anti-rabbit  F(ab)2.  Plus  and 
minus  signs  indicate  whether 
or not the samples were boiled 
in  SDS  before  electrophore- 
sis.  The  immunoblot  shows 
that  the  affinity-purified  anti- 
bodies  to  canine  ventricular 
phospholamhan  specifically 
bind  to  the  high  (25  kD; 
PLBu)  and  low  (5-6  kD; 
PLBL)  molecular  mass  forms 
of phospholamban. 
Materials and Methods 
Preparation and Characterization of  Affinity-purified 
Antibodies to Canine Cardiac  Phospholamban 
Canine cardiac phospholamban was purified according to the procedure of 
Jones et al.  (10).  Rabbit antiserum to canine cardiac phospholamban was 
prepared  and characterized as previously  described by Jones et al.  (10). 
Affinity-purified  rabbit  antibodies  to  cardiac  phospholamban  were  pre- 
pared according to the procedure of Fowler and Bennett (5) by adsorption 
of the rabbit antiserum to phospholamban electrophoretically transferred to 
nitrocellulose sheets (12). Briefly, highly purified untreated phospholamban 
(200 ~tg) was separated from minor contaminants by electrophoresis on 8 % 
slab gels (23).  The separated proteins on the slab gels were subsequently 
transferred electrophorefically to nitrocellulose paper.  The position of the 
high molecular  mass  form of phospholamban  on  the  nitrocellulose  was 
identified by indirect immunostaining of a narrow strip of the nitrocellulose 
sheet according to the procedure described by Towbin et al. (34). The por- 
tion of the nitrocellulose sheet containing the high molecular mass form 
of phospholamban was then excised and used as the affinity support for ad- 
sorption and elution of purified phospholamban antibodies (12). 
The  specificity  of affinity-purified antibodies to  canine cardiac  phos- 
pholamban was verified by indirect immunostaining of nitrocellulose blots 
of canine sarcoplasmic  reticulum proteins separated by SDS  PAGE (34). 
The details of this procedure were performed as previously described (11, 
15), except that affinity purified antibodies to phospholamban from canine 
ventricular muscle (0.5 ~tg/mi in 0.15 M NaC1,  10 mM Tris-HC1  [pH 7.2], 
and 3 % BSA) were used as the primary reagent.  Goat anti-rabbit gamma 
globulin-peroxidase  conjugate  (Bio-Rad  Laboratories,  Richmond,  CA) 
was used as the secondary reagent. 
Dissection, Fixation, and Sectioning of  Canine and 
Rat Ventricular  Muscle 
Three adult mongrel dogs and two adult female Wistar rats were used in this 
study. The dogs were anaesthetized with sodium barbitol and the hearts ex- 
cised. The rats were killed by cervical dislocation. Bundles of ventricular 
muscle fibers were quickly dissected and fixed by a two-step procedure as 
previously described (13). Subsequently, the bundles of fixed cardiac muscle 
tissue were washed, infused with 0.6 M sucrose, and 4-6-gm thick cryostat 
(13) and 80-100-nm thick ultracryomicrotomy sections (15, 33) cut as previ- 
ously described. 
Indirect Immunofluorescence Labeling 
Immunofluorescence labeling of cryostat sections of fixed canine and rat 
ventricular  muscle  tissue  was  carried  out  as  previously  described  (13). 
Affinity-purified antibodies to canine cardiac phospholamban (20 ~tg/mi) in 
pH 7.4 PBS were used as the primary reagent. The gamma globulin fraction 
of goat anti-rabbit serum conjugated to fluorescein (diluted  1:20;  Miles- 
Yeder,  Rehevat, Israel) was used as the secondary reagent. For preadsorp- 
tion,  10 ~tg of affinity purified antibodies to canine cardiac phospholamban 
were incubated with either 0 or 7.5 I~g highly purified phospholamban (10) 
as previously described (13).  The supernatants obtained by centrifugation 
were  used  in  the  indirect  immunofluorescence-labeling  assay.  The  im- 
munofluorescence cryostat sections were examined in a Zeiss photomicro- 
scope provided with an epi-fluorescence attachment and a  phase contrast 
condenser.  The  fuorescence  pictures  were  photographed  on  TRI  X-100 
film. 
Indirect Immunoelectron Microscopical  Labeling 
Immnnoelectron microscopical labeling of ultracryomicmtomy sections of 
fixed canine ventricular muscle fibers was carried out as  previously  de- 
scribed (14, 33). Affinity-purified antibodies to phospholamban (20 gg/ml 
in PBS) were used as the primary reagent. Affinity purified goat anti-rabbit 
gamma  globulin  conjugated  to  colloidal  gold  (5-10  nm;  Janssen  Phar- 
maceutica, Beerse, Belgium) was used as the secondary reagent in the label- 
ing procedures. After the immunolabeling, the ultrastructural details of the 
ultracr~microtomy sections were visualized by first osmicating, dehydrating, 
and postembedding the immunolabeled frozen sections in LR white acrylic 
resin (London Resin Co. Ltd., London, United Kingdom) and then subject- 
ing the specimen to positive staining with uranyl acetate and lead citrate as 
described by Keller et al. (16). In some cases, treatment of the immunnla- 
beled  sections with tannic acid  (1%)  followed  the osmication  step.  This 
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f) and rat (g and h) ventricular  myocardium as observed by indirect 
immunofluorescence  labeling. Fixed adult canine (a-f) and unfixed 
rat  (g and h)  ventricular muscle tissues  were  cryostat-sectioned 
(5-8 txm) transversely (a and g) and longitudinally  (b-f  and h), and 
labeled with phospholamban antibodies (a, b,  d, f-h)  and with 
phospholamban antibodies preadsorbed  with highly purified phos- 
pholamban (c).  In transverse  sections  (a  and g),  an  irregular 
polygonal-staining  pattern was observed.  Comparison between the 
fluorescent staining  pattern infwith the phase-contrast  image of the 
same field (e,  black arrowheads) shows that regular fluorescent 
staining present in the 1-band region appears as short rods oriented 
parallel to the  long axis of the myofiber (d and h,  white arrow- 
heads). Regular fluorescent staining in the A-band region consists 
of small bright foci in the central region of the A-band (d, white 
arrows). The intensity  of staining  observed after labeling  with phos- 
treatment enhanced  the visualization  of the electron  dense structures (feet) 
spanning the  gap between junctional sarcoplasmic reticulum and sar- 
cotemma. 
Quantitation 
The relative  density  of the phospholamban  labeling  per unit length of sar- 
coplasmic reticulum membrane was compared with that of sarcolemmal 
membrane of canine ventricular  muscle cells as follows. 
Ultracryomicrotomy  sections  of canine  ventricular  myocardium  obtained 
from three dogs were labeled  with either affinity-purified  rabbit antibodies 
to phospholamban  or with normal rabbit gamma globulin by the indirect 
immunogold-labeling  technique  described  above. Sections  containing  well- 
delineated  sarcoplasmic  reticulum  and sarcolemma  were identified,  and ten 
regions of myocardial  cells containing  well-delineated  sarcoplasmic reticu- 
lure were photographed at random. For each photomicrograph (go,o00×) 
containing well-delineated  sarcoplasmic reticulum, three to five micro- 
graphs containing  sarcolemma  were photographed at random  along  the pe- 
riphery of myocardial cells in the same region of the section. The length 
of the sarcoplasmic reticulum membrane and the sarcolemma in each 
micrograph was measured using a computer-aided  digital  tracer. The num- 
ber of colloidal  gold particles (Nt) present within 30 nm of either side of 
the total length (Lt) of the sarcolemma  and/or the sarcoplasmic  reticulum 
membranes were counted. The maximal distance between a membrane- 
associated antigen  and a colloidal  gold particle  conjugated  to the secondary 
antibody  reagent  is equal  to the sum of the maximal  diameter  of each of the 
labeling  reagents, i.e., 24-28 nm. The relative density (Nd) of the label- 
ing per micrometer  sarcoplasmic  reticulum  was calculated for each micro- 
graph according  to the formula  Nd = Nt/Lt. The total number  of colloidal 
gold particles present within 30 run of the total length of the extracellular 
and cytoplasmic  side of the sarcolemma  was counted  and the density  of gold 
particles per micrometer  of the extracellular  and intracellular  side of the 
membrane  calculated for groups of three to five micrographs as described 
above. 
Results 
Antibody Specificity 
The specificity of affinity-purified antibodies to canine car- 
diac phospholamban studies was demonstrated by indirect 
immunostaining  of purified canine cardiac phospholamban 
and sarcoplasmic reticulum proteins previously separated by 
SDS PAGE (34) and blotted onto nitrocellulose. As shown 
in Fig. 1, affinity-purified  antibodies to phospholamban were 
bound to single protein bands of 25,000 and 5,000-6,000 d, 
which correspond to the high (PLBH)  and low (PLBL) mo- 
lecular mass forms of phospholamban in cardiac sarco- 
plasmic  reticulum vesicles.  These  results  demonstrate 
that the affinity-purified antibodies to cardiac phospho- 
lamban are  indeed monospecific for phospholamban in 
canine ventricular muscle. 
lmmunofluorescence  Labeling 
To determine the distribution of phospholamban in myocar- 
dial tissue, transverse and longitudinal cryostat sections of 
fixed canine (Fig. 2, a-f)  and rat ventricular muscle (Fig. 
2, g and h) were labeled with antibodies to phospholamban 
by the indirect irnmunofluorescence-staining  technique. Ex- 
amination of these sections showed that all myocardial fibers 
were strongly and specifically labeled (Fig. 2 a). At a partic- 
ular phospholamban antibody concentration, the  labeling 
pholamban antibodies (b)  was  greatly reduced  when the phos- 
pholamban antibodies were  preadsorbed  with purified phospho- 
lamban before labeling (c)./, Intercellular space; N, nucleus; ID, 
intercalated disc. Short white arrows in a point to the outline of a 
myocardial cell. Bars,  2.5 ~tm. 
Jorgensen and Jones Ultrastructural  Localization of Phospholamban  1345 Figure 3. Gold  particles are densely and fairly uniformly distributed throughout the network sarcoplasmic reticulum (n-SR) in the A-band 
and the I-band regions of  the myocardial  cell. Generally,  myofibrils  are unlabeled by gold particles. However,  discrete areas densely labeled 
with gold  particles can occasionally be observed (thin arrows). Since myofibrils  are generally unlabeled, it is assumed that such discrete 
areas labeled with colloidal gold represent labeling of SR not visualized by the positive-staining  procedure. Z, Z-line; M, M-line. Bar, 
0.1 ~un. 
was more intense in canine (Fig. 2 a) than in rat ventricular 
myocardial cells  (Fig.  2  g).  By contrast,  smooth muscle 
cells, fibroblasts, and endothelial cells were only labeled at 
the level  of the background (not shown).  Arterial smooth 
muscle cells in cryosections from unfixed myocardial tissue 
were faintly but positively labeled in the perinuclear region 
of the cells (not shown).  Since this staining intensity was 
greatly diminished after fixation, it was unfeasible to assess 
the specificity of this staining pattern by adsorption of phos- 
pholamban before the immunofluorescence labeling. How- 
ever, the presence of phospholamban in microsomes isolated 
from canine aorta was recently demonstrated by the Western 
blotting technique (25). 
In transverse sections of canine (Fig. 2 a) and rat myocar- 
dial tissue labeled with antibodies to phospholamban (Fig. 
2 g), a polygonal staining pattern was observed within the 
cytosol of each myofiber. The number of sides, as well as the 
length of the sides, varied from one polygon to the next. The 
labeling of the cell periphery appeared to be discontinuous 
(arrows, Fig. 2 a). 
In longitudinal sections of canine (Fig. 2, b, d, and  f) and 
rat (Fig. 2 h) myocardial tissue, comparison between the im- 
munofluorescence staining pattern (Fig. 2f) and the position 
of the A- and I-bands (black arrowheads,  Fig. 2  e)  in the 
same  field,  as  determined by  phase  contrast microscopy 
(Fig. 2 e), showed that intense regular fluorescence labeling 
was present throughout the I-band region (white arrowheads, 
Fig.  2,  d  and h).  Furthermore, a  regular staining pattern 
limited to the center of the A-band region could frequently 
be observed (arrows, Fig. 2 d). It should be noted that inter- 
calated discs (ID; Fig. 2 b) were only labeled at the level of 
the background (Fig. 2 c). 
To demonstrate the specificity of  the immunofluorescence- 
staining patterns observed in canine cardiac muscle labeled 
with antibodies to canine phospholamban (Fig. 2, a, b, d, 
and  f), the supernatant from phospholamban-adsorbed anti- 
bodies to phospholamban were used in the indirect immuno- 
fluorescence-staining procedure. As shown in Fig. 2 c, the 
intensity of the  immunofluorescence-staining pattern  ob- 
served in Fig. 2 b was greatly diminished after labeling with 
the adsorped phospholamban antibodies. 
Immunoelectron Microscopical Labeling 
The distribution of  phospholamban in myocardial cells as de- 
termined by immunofluorescence studies corresponded  in 
general to that of the Ca2+-ATPase of the cardiac sarcoplas- 
mic reticulum in rat myocardial cells as previously deter- 
mined by immunoelectron microscopical labeling (15). How- 
ever, to determine the distribution of phospholamban more 
precisely, these studies were extended to the ultrastructural 
level of resolution. 
Longitudinal ultracryomicrotomy sections of fixed adult 
canine myocardial tissue  were  labeled with antibodies to 
phospholamban by the indirect immunogold-labeling tech- 
nique (14, 33).  To visualize the ultrastructural detail of the 
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phospholamban labeling in the 
network sarcoplasmic reticu- 
lum.  The photographs  show 
the same field of a portion of 
Fig. 3 b taken at +6 and -6  ° 
angles from the original (0  °) 
position  of  the  goniometer 
stage.  Examination  of  the 
stereopair with a steroscopic 
binocular lens shows that the 
region of the network sarco- 
plasmic reticulum that is not 
labeled  with  gold  particles 
(black arrowheads)  is  posi- 
tioned relatively deep into the 
section, whereas the gold par- 
ticles  are  generally confined 
to the upper portion of  the sec- 
tion.  Note that  the  structure 
labeled  c-SR  is  continuous 
with  the  network  sarcoplas- 
mic  reticulum  (n-SR). c-SR, 
corbular sarcoplasmic reticu- 
lum. Bar, 0.1 lain. 
cardiac muscle membranes,  the immunolabeled ultracryo- 
microtomy  sections  were  subsequently  osmicated,  dehy- 
drated, embedded in LR white resin (London Resin Co. Ltd.), 
and positively labeled according to the procedure of Keller 
et al. (16). Although this procedure for visualizing ultrastruc- 
tural detail has greatly improved the delineation of cardiac 
membranes, it has so far not permitted the visualization of 
the feet, which in sections of epon-embedded muscle tissue 
have been shown to bridge the peripheral and the interior 
junctional sarcoplasmic reticulum membrane with the sar- 
colemmal and  the transverse tubular  membranes,  respec- 
tively (3). The addition of tannic acid during the osmication 
step has now enabled us to visualize the feet structures de- 
scribed  above in  immunolabeled ultracryomicrotomy sec- 
tions (arrowheads; Figs.  6,  c and d,  and 8). 
Examination of the distribution of gold particles in myo- 
cardial cells showed that the gold particles were densely dis- 
tributed over the  sarcoplasmic  reticulum (SR,  Figs.  3-8; 
Table I). By contrast, the sarcolemma (SL, Fig. 6; Table I), 
the  intercalated  disc  (ID,  Fig.  7),  the  transverse  tubular 
membrane (T, Fig. 8), the mitochondria (M, Fig. 8), and the 
myofibrils were very sparsely labeled at a level similar to that 
of  the background. There were also, however, discrete regions 
over some myofibrils (thin arrows; Fig. 3) and over the pe- 
riphery of the occasional mitochondrion (not shown) that 
were  densely  labeled  with  gold  particles  but  apparently 
lacked  sarcoplasmic  reticulum.  Since  most  mitochondria 
(Fig. 8) and myofibrils (Figs. 3, 5 a, 6, a-d, and 8) were only 
sparsely labeled and since the sarcoplasmic reticulum has 
been shown to be present in these regions, it seems reason- 
able to assume that these discrete regions of labeling over 
myofibrils and mitochondria represent sarcoplasmic reticu- 
lum not visualized by the positive staining. 
Network Sarcoplasmic Reticulum 
Simultaneous  visualization  of the  sarcoplasmic  reticulum 
and the colloidal gold particles showed that the density of 
colloidal gold particles was  quite uniform throughout the 
network sarcoplasmic reticulum in both the I-band and the 
A-band (n-SR,  Fig. 3) regions of the sarcomeres present in 
the interior as well as the subsarcolemmal regions (n-SR, 
Fig. 6, b  and d) of myocardial cells. 
There are also, however, regions of network sarcoplasmic 
reticulum without colloidal gold particles (arrowheads; Fig. 
4 a). Since ultrastructural features, including the sarcoplas- 
mic reticulum, can be visualized throughout the thickness of 
the section while the antibodies might only penetrate the up- 
per portion of the  section,  it  is  likely that  the  unlabeled 
regions of the network sarcoplasmic reticulum were not at 
the upper region of the section and thus not exposed to the 
antibody-labeling reagents. To evaluate this possibility some 
sections were examined by stereo electron microscopy. The 
results showed that generally most of the colloidal gold parti- 
cles were present near the top surface of the thin frozen sec- 
tion (Fig. 4, a  and b). 
Corbular Sarcoplasmic Reticulum 
Vesicular  structures  localized  in  the  interfibrillar  spaces 
close to the Z-line were frequently observed to be labeled 
with gold particles (c-SR; Figs. 4 and 5). The gold particles 
were either distributed over the surface of  the vesicular struc- 
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tures present in close vicinity to the Z-lines (c-SR in a and b), how- 
ever some vesicular structures (asterisk, b) are not labeled. Note 
that gold particles are either associated  with the surface  of  the vesic- 
ular structure (triangle, a) or associated with the cytoplasmic  side 
of its membrane (circle, b). Z, Z-line; n-SR, network sarcoplasmic 
reticulum, c-SR, corbular sarcoplasmic reticulum. Bar, 0.1 lain. 
ture (triangle, Fig. 5 a) or associated with the cytoplasmic 
surface of these vesicles (circle; Fig. 5 b).  Stereo imaging 
of these vesicles suggested that they are continuous with the 
network sarcoplasmic reticulum (Fig. 4). Some of the vesic- 
ular structures were unlabeled by gold particles (asterisk, 
Fig. 5 b). 
Junctional Sarcoplasmic Reticulum 
Examination of the distribution of gold particles in the sub- 
sarcolemmal region of the ventricular myocytes showed that 
the gold particles were fairly densely distributed over the 
nonjunctional regions of the junctional sarcoplasmic reticu- 
tum not closely apposed to either the sarcolemma (large ar- 
rows; Fig. 6, c and d) or the transverse tubules (J-SR; Fig. 
8).  By contrast, the density of gold particles over the junc- 
tional  portion  of  the  junctional  sarcoplasmic  reticulum 
closely apposed to either the interior or the peripheral junc- 
tional sarcoplasmic reticulum was much lower than that over 
the nonjunctional portion and similar to that of the back- 
ground.  The  apparent absence of gold particles  over the 
junctional portion of the junctional sarcoplasmic reticulum 
was  especially  evident  when  the  fixation procedure  had 
resulted in a moderate increase in the distance between the 
sarcolemma and the junctional portion of the sarcoplasmic 
reticulum (Fig. 6, c and d). 
The Relative Distribution of  Phospholamban in 
Sarcoplasmic Reticulum and Sarcolemma 
From the qualitative examination of  the density of gold label- 
ing of the different subcellular organelles, the results pre- 
sented showed that the network and perhaps also the corbular 
sareoplasmic reticulum are densely labeled with antibodies 
to phospholamban, while the junctional portion of the in- 
terior and peripheral junctional sarcoplasmic reticulum and 
the sarcolemma appeared to be labeled at the level of the 
background. 
Comparison  of the  relative  density  of phospholamban 
labeling in the sarcoplasmic reticulum with that of the cyto- 
plasmic and extracellular sides of the sarcolemma showed that 
the density of gold particles per micrometer of sarcoplasmic 
reticulum was ~35 times higher than that of the cytoplasmic 
side of the sarcolemma, and --150 times higher than that of 
the extracellular side of the sarcolemma (Table I). The den- 
sity of the gold particles associated with the extracellular 
side of the sarcolemma was found to be similar to that of the 
background (Table I). Ultrastructural studies of the cardiac 
sarcoplasmic  reticulum have  shown that the distance be- 
tween the sarcolemma and the junctional sarcoplasmic retic- 
ulum is between 10-20 nm (3).  Examination of the distribu- 
tion  of  the  gold  particles  that  could  theoretically  be 
associated with the cytoplasmic side of the sarcolemma (i.e., 
located within 30 nm of the sarcolemma) showed that most 
("o70%)  of these particles were clustered and present over 
positively  stained  sarcoplasmic  reticulum  in  the  subsar- 
colemmal region of myocardial cells (Fig. 6 a). 
Discussion 
The results presented show that phospholamban is densely 
and uniformly  distributed throughout the network sarcoplas- 
mic reticulum in canine ventricular muscle cells in situ. The 
vesicular structures containing phospholamban present  in 
the interfibrillar spaces in the vicinity of the Z-line region 
are tentatively  identified  as the specialized nonjunctional sar- 
coplasmic reticulum called the corbular sarcoplasmic reticu- 
lum (1, 4, 28). Phospholamban appears to be absent from the 
junctional portion of the junctional sarcoplasmic reticulum 
closely apposed to either the sarcolemma or the transverse 
tubules in cardiac cells. Comparison of  these results with our 
previous immunoelectron microscopical studies of  the distri- 
bution of the  Ca2+-ATPase in  rat ventricular muscle  (15) 
suggests that both the Ca2+-ATPase and phospholamban are 
present in the network sarcoplasmic reticulum but absent 
from the junctional portion of the sarcoplasmic reticulum. 
The Journal of Cell Biology,  Volume 104, 1987  1348 Figure 6. In the subsarcolemmal region along the lateral sarco!emmal membrane of canine ventricular myocardial ceils, phospholamban 
is fairly uniformly distributed over network sarcoplasmic reticulum (a, b, and d, medium arrows;  b and d, n-SR) and the cytoplasmic 
phase of the junctional sarcoplasmic reticulum (J-SR,  c and d, thick arrows) present in this region of the cell. By contrast, the junctional 
portion of the junctional sarcoplasmic reticulum (c and d, small arrows) is not labeled by gold particles. Note that regularly spaced electron 
dense material is bridging the sarcolemma (SL) and the junctional portion of the junctional sarcoplasmic reticulum (large arrowheads, 
c and d). Similarly the sarcolemma appears to be labeled only at the level of the background (a-d, thin arrows).  Z, Z-line; CC, cell coat. 
Bars, 0.1  gm. 
Jorgensen and Jones Ultrastructural Localization of Phospholamban  1349 Figure 7. In the subsarcolemmal region along the intercalated discs (ID), gold particles are present over the network sareoplasmic reticulum 
(n-SR) but absent from the sarcolemma. Bar, 0.1 lun. 
These results are consistent with the idea first proposed by 
Kirchberger et  al.  (17) that  phospholamban  regulates  the 
Ca  2+ transport activity of the Ca2+-ATPase localized to the 
network sarcoplasmic reticulum in cardiac muscle. 
Recent  immunoelectron  microscopical  studies  (unpub- 
lished observations) and freeze fracture studies (1) of cardiac 
sarcoplasmic reticulum suggest that the Ca2+-ATPase is ab- 
sent from corbular sarcoplasmic reticulum. This region of 
the  sarcoplasmic reticulum has previously been shown to 
contain the Ca2+-binding protein calsequestrin and may per- 
haps  function as a  Ca  2+ storage and/or release site in the 
sarcoplasmic reticulum (11, 14). The localization of phos- 
pholamban to the corbular sarcoplasmic reticulum supports 
the possibility that phospholamban might have an additional 
function  in  the  corbular  sarcoplasmic  reticulum  distinct 
from its function as a  regulator of the Ca2+-ATPase. Dou- 
ble-labeling experiments with antibodies to the Ca2÷-ATPase 
at the network sarcoplasmic reticulum and phospholamban 
are in progress to determine definitively whether phospho- 
lamban is indeed present in this specialized nonjunctional 
sarcoplasmic reticulum previously shown to lack the Ca  2+- 
ATPase. 
Several investigators studying sarcolemmal protein phos- 
phorylation in intact cellular (7, 8) and isolated membrane 
fractions (26, 27) have demonstrated the presence of a phos- 
pholamban-like protein in membrane fractions enriched in 
sarcolemmal vesicles. Thus it has been proposed that beta- 
adrenergic  stimulation  of phosphorylation of the  putative 
sarcolemmal-associated phospholamban might enhance the 
inotropic state of myocardial cells (7, 8, 26, 27).  However, 
this  interpretation has  been disputed on the basis  of bio- 
chemical studies suggesting that the sarcolemmal-associated 
phospholamban  is  not  an  integral  component of the  sar- 
colemma but rather a contaminant originating from the sar- 
coplasmic reticuhm (9, 10, 22). This interpretation is further 
supported by the recent finding that the phospholamban con- 
tent of highly purified sarcolemmal vesicles is only 8 % of 
that of purified sarcoplasmic reticulum vesicles when com- 
Table L Relative Distribution of  Phospholamban 
in the Sarcoplasmic Reticulum and the Sareolemma 
of Canine Ventricular Myocytes* 
No.  gold* 
Total membrane  particles/0.m 
Label  Membrane  size  of membrane 
/dm 
Phospholamban  Network 
antibodies  sarcoplasmic  33.3  31.1  + 7.6 
reticulum 
Phospholamban  §Sarcolemma:  197 
outside  0.2  + 0.2 
inside  0.9  + 0.3 
Normal  §Sarcolemma: 50 
rabbit globulin  outside  0.2 
inside  0.2 
* See Materials and Methods. 
The  entire length of network  sarcoplasmic reticulum or  sarcolemma was 
measured in each micrograph.  The  number of gold particles/micrometer of 
membrane  was then averaged over the number of micrographs used in the 
study and a  SD calculated. 
§ Since the maximum distance between a  sarcolemma-associated antigen and 
the center of the colloidal gold particles conjugated to the secondary antibody 
is 25  nm,  gold particles within 30  nm of the outer or  inner surface of the 
sacrolemma were enumerated. 
The Journal of Cell Biology, Volume 104,  1987  1350 Figure 8.  In the region where the junctional sarcoplasmic reticulum (J-SR) is closely apposed to transverse tubules (T), gold particles 
are densely distribuleat over the cytoplasmic  phase of the junctional sarcoplasmic reticulum (black arrows) and less densely over the junc- 
tional portion of  the  junctional sarcoplasmic  reticulum. Gold particles are absent from the T-tubular  membrane (arrowheads). M, Mitochon- 
drion; Z, Z-line; n-SR,  network sarcoplasmic reticulum. Bar, 0.1 lain. 
parisons are expressed per milligram of membrane protein 
isolated (24). 
Comparison of the relative density of phospholamban im- 
munolabeling of the sarcoplasmic reticulum with that of the 
sarcolemma supports the proposal that phospholamban is 
confined to the sarcoplasmic reticulum in cardiac muscle. 
Thus,  the density of phospholamban in  the  network  sar- 
coplasmic reticulum was found to be •35-fold  higher than 
on the cytoplasmic side of the sarcolemma, which was only 
about three-  to fourfold higher than background labeling. 
The finding that the majority of the phospholamban labeling 
on the cytoplasmic side of the sarcolemma was clustered and 
present over the sarcoplasmic reticulum in the subsarcolem- 
mal region of the cell is consistent with the possibility that 
specific phospholamban labeling in this region of the myo- 
cardial cell represents phospholamban associated with the 
nonjunctional portion of the junctional sarcoplasmic reticu- 
lum and that phospholamban is absent from the non  junc- 
tional portion of the sarcolemma. This suggestion is also 
supported by the observation that phospholamban labeling of 
well-delineated and perpendicularly cut  junctional regions of 
the sarcolemma and junctional sarcoplasmic reticulum (Fig. 
6, c and d) is densely distributed over the nonjunctional por- 
tion of the junctional sarcoplasmic reticulum while absent 
from the sarcolemma and the junctional portion of the junc- 
tional sarcoplasmic reticulum. However,  since the maximal 
distance between an antigen associated with the cytoplasmic 
side of the sarcolemma and the center of the colloidal gold 
particle conjugated to the secondary antibody reagent is 30 
nm while the distance between the sarcolemma and the junc- 
tional sarcoplasmic reticulum is only 10-20 nm, the immu- 
nogold-labeling technique used in the present study cannot 
exclude the possibility that the junctional portion of the sar- 
colemma closely apposed to junctional sarcoplasmic reticu- 
lum is specifically labeled with antibodies to phospholam- 
ban.  Such labeling,  however,  is  well below  the  levels  of 
phospholamban detected in partially purified sarcolemmal 
fractions (7,  8, 26,  27). 
In conclusion, the results presented clearly show that the 
bulk of the phospholamban detected in isolated sarcolemmal 
vesicles (7,  8, 26,  27)  is likely to represent contamination 
with sarcoplasmic reticulum vesicles. Thus, recent reports 
by Louis et al.  (21) and Lamers et al.  (18) suggesting that 
phospholamban in cardiac muscle is an integral component 
Jorgensen  and Jones  Ultrastructural Localization of Phospholamban  1351 of both the  sarcoplasmic  reticulum  and  the  sarcolemma 
should be viewed with caution. 
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